Our first quarter issue features leading insights from key opinion leaders on a variety of topics concerning business development in the pharma and biopharma outsourcing sector.
Investing in Form-Fill-Seal Technology, Lluc Mercadé, Grifols
Aligning the Outsourcing Relationship, Gwenaël Servant Ph.D., Servier
Adjusting Internal Structure to Better Meet Demands of Unmet Business, James E. Gregory, UPM Pharmaceuticals
Developing and Characterizing DPI Formulations for Biologics, Constança Cacela Ph.D., Eunice Costa Ph.D., Hovione
Pharma Tackles the Big Issues, Nigel Walker, Nice Insight
Integrated Clinical Packaging, Warehousing and Transport Services Supporting Pharma and Biopharma, Gulam Jaffer, Yourway
How Agile Investment Drives Innovation, Thibaut Fraisse, Fareva
Digital Droplet PCR for Viral Vector Analysis, Diego Matayoshi, Sushma Ogram Ph.D., Susan D’Costa Ph.D., Richard O. Snyder, Ph.D., Brammer Bio
Preclinical to Nearly Commercial Virus and Viral Vector Manufacturing, Jean Bléhaut, Novasep
Investing in the Future of Potent Compounds, Frederic Desdouits, Seqens
Leveraging Operational Simulations to Design Cell Therapy Facilities, Niranjan Kulkarni, CRB USA
A World of Opportunity: What to Expect from CPhI & P-MEC China
Driving Growth of the Cell and Gene Therapy Sector, Felix Hsu, WuXi Advanced Therapies
Evolving Business Models and an Ethical Paradigm Shift, Balancing Ethical and Fiduciary Responsibilities in Drug Pricing, David Alvaro, Ph.D., Cynthia Challener, Ph.D., Emilie Branch, Nice Insight
Evolving Business Models and an Ethical Paradigm Shift, Evolving Ethical Conduct Concerns in Clinical Trials, David Alvaro, Ph.D., Cynthia Challener, Ph.D., Emilie Branch, Nice Insight
Reprioritizing to Bring FY2020 into Focus, Jeanne Thoma, Sarath Chandar, Graeme Macleod, Jon Struthers, Joe Rogus, Coralyn Gonzalez, John Creighton, SPI Pharma
Rentschler Biopharma SE Sets Foot in the U.S. to Strengthen its World-Class CDMO Position, Federico Pollano, Rentschler Biopharma SE
Preparing Middle-Market Firms to Attract Investment, Jeffrey Marlough, Castleford Capital
Setting Expectations for Facility and Business Sales in the CDMO Sector, William B. Wiederseim, PharmaBioSource
Selecting the Right Private Equity Partner to Build a Leading Outsourcing Provider, David Q. Anderson, Ampersand Capital Partners
Quality of Earnings: The Most Important Term You Probably Don’t Know, Michael Geldart, Eric Mattson, Excellere Partners
Factors Driving Consolidation in the CDMO Space, Jason Foss, Results Healthcare
Similar, Different and Constantly Varied, Steve King, 21159Pharma
U.K. Healthcare Firms Creating Value Worldwide, Hemavli Bali, Clearwater International Corporate Finance
The Value Triangle: Risk Management for RMATs, John Wass, CAI Commissioning Agents Inc.
Finding the Right Product Platform: A Personal Perspective, Ori Gutwerg
A World-Class Partner for Today’s Market, Oliver Ju, Porton Pharma Solutions
Speed and Customized Support from Gene to GMP Manufacturing, Giedrius Žunda, Biotechpharma
Pharma Makes Moves to Leverage Artificial Intelligence, Cynthia A. Challener, Ph.D., Nice Insight
Overcoming Challenges in Microbial Process Development, Elise Mous, Capua Bioservices
Twin-Screw Melt Granulation as a Platform Technology for Continuous Manufacturing, Tony Listro, Foster Delivery Science
Accelerating Biosimilar Development, John Gabrielson, KBI Biopharma
Facilitating Complex Clinical Trials For Rare Diseases, Ariette van Strien, Marken, Clinical Trial Logistics
Fill/Finish: Increasing Investment and Flexibility for Effective Manufacturing, B.J. Hull, Emergent BioSolutions
The Ideal Capsule Supplier: Using A Holistic Approach to Facilitate Customer Success, Jonathan Gilinski, CapsCanada
A Research Partner With Proven Results, Daniel Conlon, IRBM
Addressing the Challenges of Comparator Drug Sourcing for Clinical Trials, Salman Pathan, Globyz Pharm
Generics Manufacturing and Changing Equipment Needs, Justin Kadis, Federal Equipment Company
Supporting Client Projects for CDMO Success, Marc Sauer Ph.D., Mark Wellman, BioVectra
Process Understanding Central to Successful Drug Synthesis, James J. Springer, Robert Hughes, Albemarle Fine Chemistry Services
Formulated Solutions: Redefining the Consumer Healthcare Experience, Design Logic, Formulated Solutions Website Launch
Pharma’s Almanac Most Impactful Thought Leadership of 2018, Nice Insight
Collaborating for Immunotherapy Development, KshitiJ (TJ) Ladage, Nice Insight
Award-Winning Performance Driven by an Award-Winning Workplace Culture, Peter Pekos, Dalton Pharma Services
Rapid Growth in the ADC Market Drives Strategic Partnership Interest, Allan Davidson, Piramal Pharma Solutions
Understanding the FDA’s Approach to Real-World Evidence, David Alvaro, Ph.D., Nice Insight
Roundtable, Olivier Loeillot, GE Healthcare, Franco Negron, Thermo Fisher Scientific, Ed Price, PCI Synthesis, Shannon Trilli, Catalent, Jessica Martin, SGS Life Science Services
Roundtable, Franco Negron, Thermo Fisher Scientific, Andreas Persidis, Ph.D., Biovista, Ben Newton, GE Healthcare, Ed Price, PCI Synthesis